Search
Search Constraints
Start Over You searched for: Subjects Cost-Benefit Analysis ✖Remove constraint Subjects: Cost-Benefit Analysis Subjects Humans ✖Remove constraint Subjects: HumansRefine by:
- Text51
- Cost-Benefit Analysis✖[remove]51
- Humans✖[remove]51
- United States50
- Treatment Outcome18
- Randomized Controlled Trials as Topic12
- Abuse-deterrent formulations of opioids: effectiveness and value : final evidence report1
- Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report1
- Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report1
- California's nurse practitioners: how scope of practice laws impact care1
- CardioMEMS (tm) HF System (St. Jude Medical, Inc.) and Sacubitril/Valsartan (Entresto (tm), Novartis AG) for management of congestive heart failure: effectiveness, value, and value-based price benchmarks : final report1
- English51
- 1000 to 1099 0
- 1100 to 1199 0
- 1200 to 1299 0
- 1300 to 1399 0
- 1400 to 1499 0
- 1500 to 1599 0
- 1600 to 1699 0
- 1700 to 1799 0
- 1800 to 1899 0
- 1900 to 1999 0
- 2000 to 2024 51
Current results range from 2005 to 2019